Emma Furth

8PUBLICATIONS

80CO-AUTHORS

Molecular targetsCancer diagnosisMedical infection agents (incl. prions)Predictive and prognostic markersHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jul 03, 2026

CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor Resistance.

|Mar 12, 2026

Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma.

Minh T Than, Lucie Dequiedt, Rina Sor

|Feb 01, 2026

Despite simplified diagnostic criteria, intraobserver and interobserver variability remain in the interpretation of colorectal serrated polyps.

Adam L Booth, Emina E Torlakovic, Runjan Chetty

|Aug 01, 2025

MRI Detection of PDAC Response to KRAS Inhibitor Therapy-Response.

Rong Zhou, Yong Fan, Emma E Furth

|Apr 22, 2025

Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy.

Mamta Gupta, Hoon Choi, Samantha B Kemp

|Feb 21, 2024

Machine Learning Links T-cell Function and Spatial Localization to Neoadjuvant Immunotherapy and Clinical Outcome in Pancreatic Cancer.

Katie E Blise, Shamilene Sivagnanam, Courtney B Betts

Pageof 2

Frequent Collaborators

Rong Zhou

Ben Z Stanger

Cynthia Clendenin

Robert H Vonderheide

Shuwen Cao

Shyh-Ming Yang

Terence P F Gade

Natalia J Martinez

Adam Yasgar

Anton Simeonov

Frequent Collaborators

Rong Zhou

Ben Z Stanger

Cynthia Clendenin

Robert H Vonderheide